drugset / Trial / NCT05913336
A Study of Remimazolam Tosilate for Prolonged Sedation in the ICU
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of Remimazolam Tosilate for Injection for prolonged sedation(≥72h) during mechanical ventilation in the ICU.
Timeline
- Start
- 2023-06-27
- Primary completion
- 2025-03-05
- Completion
- 2025-03-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Remimazolam | Small molecule | — | Intravenous |
Indications
No indication recorded.